Retour
Fourchette du Jour
4,07 €
4,38 €
Fourchette 52 Semaines
1,32 €
5,03 €
Volume
4 195 593
Moyenne 50J / 200J
3,82 €
/
2,65 €
Clôture Précédente
4,19 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -14,0 | 0,3 |
| P/B | 5,5 | 2,9 |
| ROE % | -42,3 | 3,7 |
| Net Margin % | -79,0 | 3,8 |
| Rev Growth 5Y % | 11,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
5,42 €
+27.8%
Low: 5,25 €
High: 5,50 €
BPA Prévisionnel
-0,14 €
CA Est.
120 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,00 €
0,00 € – 0,00 €
|
220 M | 0 |
| FY2029 |
0,00 €
0,00 € – 0,00 €
|
180 M | 0 |
| FY2028 |
-0,06 €
-0,06 € – -0,06 €
|
150 M | 2 |
Points Clés
Revenue grew 11,76% annually over 5 years — strong growth
Debt/Equity of 0,10 — conservative balance sheet
Negative free cash flow of -16,05M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,20%
Capital efficient — spends only 3,43% of revenue on capex
Croissance
Revenue Growth (5Y)
11,76%
Revenue (1Y)18,96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-42,25%
ROIC-29,95%
Net Margin-78,95%
Op. Margin-88,53%
Sécurité
Debt / Equity
0,10
Current Ratio3,83
Interest Coverage-58,00
Valorisation
P/E Ratio
-14,01
P/B Ratio5,51
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18,96% | Revenue Growth (3Y) | 21,70% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11,76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 97,61M | Net Income (TTM) | -77,06M |
| ROE | -42,25% | ROA | -25,99% |
| Gross Margin | 46,85% | Operating Margin | -88,53% |
| Net Margin | -78,95% | Free Cash Flow (TTM) | -16,05M |
| ROIC | -29,95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 3,83 |
| Interest Coverage | -58,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -14,01 | P/B Ratio | 5,51 |
| P/S Ratio | 11,06 | PEG Ratio | 1,38 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,08B | Enterprise Value | 949,55M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 97,61M | 82,06M | 65,90M | 73,39M | 62,57M |
| Net Income | -77,06M | -72,49M | -133,70M | -168,72M | -32,41M |
| EPS (Diluted) | -0,31 | -0,34 | -0,65 | -0,84 | -0,19 |
| Gross Profit | 45,73M | 48,83M | 16,86M | 39,46M | 17,05M |
| Operating Income | -86,42M | -74,41M | -145,61M | -193,02M | -192,73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 296,53M | 256,08M | 304,27M | 417,57M | 571,97M |
| Total Liabilities | 100,55M | 87,25M | 84,22M | 92,21M | 124,27M |
| Shareholders' Equity | 195,98M | 168,83M | 220,05M | 325,36M | 447,69M |
| Total Debt | 20,40M | 22,84M | 25,03M | 31,89M | 29,08M |
| Cash & Equivalents | 150,49M | 88,78M | 134,64M | 162,56M | 422,84M |
| Current Assets | 249,10M | 192,61M | 231,26M | 357,14M | 511,90M |
| Current Liabilities | 65,12M | 48,22M | 44,27M | 51,33M | 49,83M |